European Pharmaceutical Review

SEPTEMBER 15, 2023

Award winners will be revealed at a networking reception on the first day of CPHI Barcelona 2023, which is running from 24-26 October. Revolutionising microencapsulation with in-air microfluidics technology for next-generation sustainable healthcare solutions. .: Are you coming to the CPHI Barcelona 2023?

Pharma 119

Pharma Manufacturing Biopharma Pharmaceutical 119

Clarivate

AUGUST 7, 2024

Express Scripts ClearNetwork (effective from early 2024) Cost-plus pricing model; includes ESI’s 65,000-plus site retail pharmacy network; prescription pricing is based on the lowest of three benchmarks: NADAC, WAC or PAC; Pharmacies receive a flat dispensing fee plus up to 15% markup.

Retail 59

Retail Marketing Competition Biopharma 59

Clarivate

MAY 14, 2024

However, availability of cost-effective biosimilars of semaglutide starting 2026 is likely to influence patient perception of the drug in a price-sensitive Chinese market, especially for obese patients in the absence of reimbursement for weight loss drugs.

Manufacturing 52

Manufacturing Marketing Leads Medicine 52

PM360

SEPTEMBER 21, 2023

Starting in 2026, the provision will affect 10 Part D drugs. This increases to 15 Part D drugs in 2026, as well as 15 Part B and D drugs in 2028, and a full 20 Part B and D drugs in 2029. Still, the law may impact claim operations and network contracts, Casberg noted.

Management 105

Management Manufacturing Sales Competition 105

Clarivate

SEPTEMBER 5, 2024

Starting in 2026, the first ten self-administered Part D drugs in the law’s cross hairs will receive price cuts of 38%-79%. With the passage of the Inflation Reduction Act (IRA), the United States government gained the ability to directly negotiate drug prices with manufacturers.

Insurance 52

Insurance Marketing Manufacturing Prescription 52

Clarify Health

MAY 4, 2022

Population health management is best supported by a data-driven approach with a structured analytics process driven by skilled and competent healthcare leaders and clinicians. Reports estimate that the healthcare analytics market size is expected to grow to $75.1 billion by 2026.

Management 52

Management Healthcare Healthcare Training 52

Clarify Health

MAY 4, 2022

Population health management is best supported by a data-driven approach with a structured analytics process driven by skilled and competent healthcare leaders and clinicians. Reports estimate that the healthcare analytics market size is expected to grow to $75.1 billion by 2026.

Management 52

Management Healthcare Healthcare Training 52

Clarify Health

FEBRUARY 6, 2024

In 2026, payers will need to send prior authorization decisions within 72 hours for urgent requests and seven business days for standard requests. Network Adequacy Among Medicare Advantage enrollees, 28% live with a mental illness, according to the Commonwealth Fund. The rule had a phased implementation approach.

Networking 52

Networking Insurance Government Management 52

pharmaphorum

JANUARY 4, 2023

The CGT market in Europe, for example, is projected to increase by 23% by 2026. Robust cryogenic infrastructure in strategic locations across the globe – ideally close to processing facilities and healthcare providers – is necessary to enable timely and reliable access to these therapies around the world and accelerate time to treatment.

Transportation 90

Transportation Manufacturing Patients Networking 90

Evolve Your Success

JANUARY 24, 2023

If you’re someone that’s trying to get into medical sales, maybe it’s pharmaceutical, medical device, or any kind of healthcare sales, then you better be tuning in to this episode. Networking, building a relationship, and not having it need to go somewhere. They’re healthcare sales reps.

Medical sales 52

Medical sales Sales Medical Education 52

Pharmaceutical Technology

JANUARY 16, 2023

Negotiated prices will not apply until 2026, but the selected medicines for Medicare price negotiations will be unveiled in September 2023. However, a looming risk on the horizon in 2023 is that the economic pain may produce downstream effects on global pharmaceutical supply chain networks. Free Report.

Pharma 64

Pharma Pharmaceutical Manufacturing Marketing 64

Pharmaceutical Technology

JANUARY 16, 2023

Negotiated prices will not apply until 2026, but the selected medicines for Medicare price negotiations will be unveiled in September 2023. However, a looming risk on the horizon in 2023 is that the economic pain may produce downstream effects on global pharmaceutical supply chain networks. Free Report.

Pharma 52

Pharma Pharmaceutical Manufacturing Marketing 52